A L Hassett1, J D Cone, S J Patella, L H Sigal. 1. Department of Medicine, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, New Brunswick 08903, USA.
Abstract
OBJECTIVE: Although 2 recent studies have found associations between catastrophizing and poor medical outcomes in patients with fibromyalgia syndrome (FMS), neither assessed these findings in comparison with a similar group of patients with chronic pain. Our study examined the complex relationships between depression, catastrophizing, and the multidimensional aspects of pain in women with FMS and compared these relationships with those in women with rheumatoid arthritis (RA). METHODS: Sixty-four FMS patients and 30 RA patients completed the Coping Strategies Questionnaire (CSQ), the Beck Depression Inventory II (BDI-II), and the McGill Pain Questionnaire. RESULTS: Compared with subjects with RA, FMS subjects scored significantly higher on the catastrophizing subscale of the CSQ. FMS patients also earned higher scores on overall depression and on the cognitive subscale of the BDI-II. Furthermore, the relationship between catastrophizing and depression was significant in the FMS group only. Regression analyses revealed that in FMS, catastrophizing as a measure of coping predicted patients' perception of pain better than demographic variables such as age, duration of illness, and education. CONCLUSION: Cognitive factors, such as catastrophizing and depressive self-statements, have a more pronounced role in the self-reported pain of patients with FMS than in patients with RA. Clinically, this indicates that treating pain and depression in FMS by adding cognitive therapy and coping skills components to a comprehensive treatment program may improve the outcomes obtained with pharmacologic interventions.
OBJECTIVE: Although 2 recent studies have found associations between catastrophizing and poor medical outcomes in patients with fibromyalgia syndrome (FMS), neither assessed these findings in comparison with a similar group of patients with chronic pain. Our study examined the complex relationships between depression, catastrophizing, and the multidimensional aspects of pain in women with FMS and compared these relationships with those in women with rheumatoid arthritis (RA). METHODS: Sixty-four FMS patients and 30 RApatients completed the Coping Strategies Questionnaire (CSQ), the Beck Depression Inventory II (BDI-II), and the McGill Pain Questionnaire. RESULTS: Compared with subjects with RA, FMS subjects scored significantly higher on the catastrophizing subscale of the CSQ. FMS patients also earned higher scores on overall depression and on the cognitive subscale of the BDI-II. Furthermore, the relationship between catastrophizing and depression was significant in the FMS group only. Regression analyses revealed that in FMS, catastrophizing as a measure of coping predicted patients' perception of pain better than demographic variables such as age, duration of illness, and education. CONCLUSION: Cognitive factors, such as catastrophizing and depressive self-statements, have a more pronounced role in the self-reported pain of patients with FMS than in patients with RA. Clinically, this indicates that treating pain and depression in FMS by adding cognitive therapy and coping skills components to a comprehensive treatment program may improve the outcomes obtained with pharmacologic interventions.
Authors: Christopher L Edwards; Alvin Killough; Mary Wood; Todd Doyle; Miriam Feliu; Camela S Barker; Priyanka Uppal; Laura DeCastro; Chante Wellington; Keith E Whitfield; Keisha-Gaye N O'Garo; Kai Morgan; Lekisha Y Edwards Alesii; Goldie S Byrd; Melanie McCabe; Veeraindar Goli; Abigail Keys; Labarron Hill; Janice Collins-McNeil; Jay Trambadia; Dariene Guinyard; Malik Muhammad; Patricia McDonald; Donald E Schmechel; Elwood Robinson Journal: Int J Psychiatry Med Date: 2014 Impact factor: 1.210
Authors: Christopher L Edwards; Mischca T Scales; Charles Loughlin; Gary G Bennett; Shani Harris-Peterson; Laura M De Castro; Elaine Whitworth; Mary Abrams; Miriam Feliu; Stephanie Johnson; Mary Wood; Ojinga Harrison; Alvin Killough Journal: Int J Behav Med Date: 2005
Authors: S van Koulil; M Effting; F W Kraaimaat; W van Lankveld; T van Helmond; H Cats; P L C M van Riel; A J L de Jong; J F Haverman; A W M Evers Journal: Ann Rheum Dis Date: 2006-08-17 Impact factor: 19.103
Authors: Robert R Edwards; Jon Giles; Clifton O Bingham; Claudia Campbell; Jennifer A Haythornthwaite; Joan Bathon Journal: Pain Med Date: 2010-03-04 Impact factor: 3.750
Authors: Adrienne L Adler-Neal; Christian E Waugh; Eric L Garland; Hossam A Shaltout; Debra I Diz; Fadel Zeidan Journal: J Pain Date: 2019-08-01 Impact factor: 5.820